XLO · Xilio Therapeutics, Inc. · Analyst Estimates
Market Cap
$51.64M
Shares
5.78M
Analyst Estimates
Compare analyst forecasts for Xilio Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1840233
CUSIP
98422T209
13F (30d)
13 filings
13 filers
Visit website
Investor relations